Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-013742
Filing Date
2025-05-19
Accepted
2025-05-19 20:52:56
Documents
1
Period of Report
2025-05-16

Document Format Files

Seq Description Document Type Size
1 form4-05202025_120553.html 4  
1 form4-05202025_120553.xml 4 5119
  Complete submission text file 0001415889-25-013742.txt   6588
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
Kihara James (Reporting) CIK: 0001816160 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 25965936